Reproductive Health

Physical activity is emerging as a critical factor in women’s health after cancer, with new evidence showing lower mortality among postmenopausal survivors who move more and sit less.

Cannabis use during pregnancy significantly increases the risk of low birth weight, preterm birth, and other poor neonatal outcomes, even after adjusting for tobacco use, a major meta-analysis finds.

A US trial has shown no local tumour recurrences in patients with exceptional responses to neoadjuvant therapy who skipped breast surgery, offering hope for future de-escalation strategies.

A large cohort study has found that chemoradiotherapy offers no survival advantage over radiotherapy alone in intermediate-risk cervical cancer patients—raising questions about current treatment practices.

A major study has shown that pregnant individuals treated with buprenorphine for opioid use disorder have lower risks of severe complications, preterm birth, and NICU admissions.

A new study reveals a potential link between certain hormonal IUDs and the onset of rosacea, with dermatologists urging awareness of symptoms and treatment options.

After 25 years of pioneering research, the UK celebrates its first birth following a womb transplant, offering new hope to women without a functioning uterus.

Research presented at ESCMID Global 2025 reveals how Schistosoma haematobium infection and praziquantel treatment may trigger gene activity linked to cervical cancer risk in women.